Literature DB >> 25550917

MDA-7/IL-24 inhibits cell survival by inducing apoptosis in nasopharyngeal carcinoma.

Cheng Lin1, Haibin Liu2, Li Li2, Qiubei Zhu2, Huanhai Liu2, Zhenghua Ji2, Jianchun Liao2, Juntian Lang2, Jian Wu2, Jingping Fan2.   

Abstract

AIMS: Nasopharyngeal carcinoma (NPC) is the most common primary malignancy of the nasopharynx. Due to its local recurrence and distant metastasis, conventional therapy is usually ineffective. MDA-7/IL-24 (melanoma differentiation associated gene 7), a member of the IL10 family of cytokines, inhibits growth of various human cancer cells, but the underlying mechanism is largely unknown. There is no report of mda-7 in nasopharyngeal carcinoma. We aimed to investigate the role of MDA-7/IL-24 in NPC.
METHODS: Immune defective adenoviral vector carrying the gene was produced, infected NPC CNE cells and observed its growth, cell proliferation, apoptosis and the effect of combination with chemotherapy.
RESULTS: The results showed that (1) MDA-7/IL-24 inhibited NPC CNE cell growth and survival; (2) mda-7 induced cell apoptosis and death; (3) MDA-7/IL-24 in collaboration with chemotherapy induced cell apoptosis significantly; (4) MDA-7/IL-24 induced cell apoptosis by down-regulation of anti-apoptosis molecules such as Bcl-2 and Bcl-xl and up-regulation of caspase 3.
CONCLUSION: The results suggested that MDA-7/IL-24 had obvious therapeutic effect in NPC cells. It is verified that adenovirus mediated MDA-7/IL-24 represents a potentially important new approach to NPC therapy.

Entities:  

Keywords:  MDA-7/IL-24; cell survival; nasopharyngeal carcinoma

Year:  2014        PMID: 25550917      PMCID: PMC4276175     

Source DB:  PubMed          Journal:  Int J Clin Exp Med        ISSN: 1940-5901


  31 in total

1.  A serotype 5/3 adenovirus expressing MDA-7/IL-24 infects renal carcinoma cells and promotes toxicity of agents that increase ROS and ceramide levels.

Authors:  Margaret A Park; Hossein A Hamed; Clint Mitchell; Nichola Cruickshanks; Rupesh Dash; Jeremy Allegood; Igor P Dmitriev; Gary Tye; Besim Ogretmen; Sarah Spiegel; Adly Yacoub; Steven Grant; David T Curiel; Paul B Fisher; Paul Dent
Journal:  Mol Pharmacol       Date:  2010-11-30       Impact factor: 4.436

2.  Clinical and local biological effects of an intratumoral injection of mda-7 (IL24; INGN 241) in patients with advanced carcinoma: a phase I study.

Authors:  C Casey Cunningham; Sunil Chada; James A Merritt; Alex Tong; Neil Senzer; Yuan Zhang; Abner Mhashilkar; Karen Parker; Sasha Vukelja; Don Richards; Jill Hood; Keith Coffee; John Nemunaitis
Journal:  Mol Ther       Date:  2005-01       Impact factor: 11.454

3.  Genomic structure, chromosomal localization and expression profile of a novel melanoma differentiation associated (mda-7) gene with cancer specific growth suppressing and apoptosis inducing properties.

Authors:  E Y Huang; M T Madireddi; R V Gopalkrishnan; M Leszczyniecka; Z Su; I V Lebedeva; D Kang; H Jiang; J J Lin; D Alexandre; Y Chen; N Vozhilla; M X Mei; K A Christiansen; F Sivo; N I Goldstein; A B Mhashilkar; S Chada; E Huberman; S Pestka; P B Fisher
Journal:  Oncogene       Date:  2001-10-25       Impact factor: 9.867

4.  Wnt signaling controls the phosphorylation status of beta-catenin.

Authors:  Mascha van Noort; Jan Meeldijk; Ruurd van der Zee; Olivier Destree; Hans Clevers
Journal:  J Biol Chem       Date:  2002-02-07       Impact factor: 5.157

5.  Adenovirus-mediated mda-7 (IL24) gene therapy suppresses angiogenesis and sensitizes NSCLC xenograft tumors to radiation.

Authors:  Takashi Nishikawa; Rajagopal Ramesh; Anupama Munshi; Sunil Chada; Raymond E Meyn
Journal:  Mol Ther       Date:  2004-06       Impact factor: 11.454

Review 6.  mda-7/IL-24, a novel cancer selective apoptosis inducing cytokine gene: from the laboratory into the clinic.

Authors:  Paul B Fisher; Rahul V Gopalkrishnan; Sunil Chada; Rajagopal Ramesh; Elizabeth A Grimm; Myrna R Rosenfeld; David T Curiel; Paul Dent
Journal:  Cancer Biol Ther       Date:  2003 Jul-Aug       Impact factor: 4.742

Review 7.  Interleukin 24: mechanisms and therapeutic potential of an anti-cancer gene.

Authors:  Erin L Whitaker; Valery A Filippov; Penelope J Duerksen-Hughes
Journal:  Cytokine Growth Factor Rev       Date:  2012-09-14       Impact factor: 7.638

Review 8.  MDA-7/IL-24 is a unique cytokine--tumor suppressor in the IL-10 family.

Authors:  Sunil Chada; R Bryan Sutton; Suhendan Ekmekcioglu; Julie Ellerhorst; John B Mumm; Wolfgang W Leitner; Heng-Yin Yang; Aysegul A Sahin; Kelly K Hunt; Kerry L Fuson; Nancy Poìndexter; Jack A Roth; Rajagopal Ramesh; Elizabeth A Grimm; Abner M Mhashilkar
Journal:  Int Immunopharmacol       Date:  2004-05       Impact factor: 4.932

Review 9.  Nuclear factor-kappa B and cancer: its role in prevention and therapy.

Authors:  Alok C Bharti; Bharat B Aggarwal
Journal:  Biochem Pharmacol       Date:  2002-09       Impact factor: 5.858

10.  PERK-dependent regulation of ceramide synthase 6 and thioredoxin play a key role in mda-7/IL-24-induced killing of primary human glioblastoma multiforme cells.

Authors:  Adly Yacoub; Hossein A Hamed; Jeremy Allegood; Clint Mitchell; Sarah Spiegel; Maciej S Lesniak; Besim Ogretmen; Rupesh Dash; Devanand Sarkar; William C Broaddus; Steven Grant; David T Curiel; Paul B Fisher; Paul Dent
Journal:  Cancer Res       Date:  2010-01-26       Impact factor: 12.701

View more
  4 in total

1.  Bifidobacterium breve as a delivery vector of IL-24 gene therapy for head and neck squamous cell carcinoma in vivo.

Authors:  L Wang; I Vuletic; D Deng; W Crielaard; Z Xie; K Zhou; J Zhang; H Sun; Q Ren; C Guo
Journal:  Gene Ther       Date:  2017-08-14       Impact factor: 5.250

2.  MDA-7/IL-24 functions as a tumor suppressor gene in vivo in transgenic mouse models of breast cancer.

Authors:  Mitchell E Menezes; Xue-Ning Shen; Swadesh K Das; Luni Emdad; Chunqing Guo; Fang Yuan; You-Jun Li; Michael C Archer; Eldad Zacksenhaus; Jolene J Windle; Mark A Subler; Yaacov Ben-David; Devanand Sarkar; Xiang-Yang Wang; Paul B Fisher
Journal:  Oncotarget       Date:  2015-11-10

3.  A Hybrid Imaging Platform(CT/PET/FMI) for Evaluating Tumor Necrosis and Apoptosis in Real-Time.

Authors:  Yulin Kang; Xiaohui Zhai; Sifen Lu; Ivan Vuletic; Lin Wang; Kun Zhou; Zhiqiang Peng; Qiushi Ren; Zhaoheng Xie
Journal:  Front Oncol       Date:  2022-06-22       Impact factor: 5.738

4.  The IL-24 gene protects human umbilical vein endothelial cells against H₂O₂-induced injury and may be useful as a treatment for cardiovascular disease.

Authors:  Zhaoxia Wang; Yang Wang; Yunfei Chen; Jiyuan Lv
Journal:  Int J Mol Med       Date:  2016-01-25       Impact factor: 4.101

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.